Michael Scolaro

Michael Scolaro

Oct 11, 2017

Group 6 Copy 65
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Making Inexpensive Insulin Using Microalgae

    This page serves as an archive of our first proof-of-concept experiments to genetically modify microalgae...

    Ebola video voice-over recording in 10 African local languages

    Ebola virus is spreading rapidly in West Africa. We are sharing a 3D animation explaining the symptoms of...

    Can a rabies vaccination booster save African Wild Dogs?

    Rabies is one of the greatest threats to the continued survival of the African wild dog (Lycaon pictus...

    Backer Badge Funded